Bavarian Nordic Announces Interim Results for the First Nine Months of 2017
November 08, 2017 01:51 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, November 8, 2017...
Bavarian Nordic afholder telefonkonference i forbindelse med offentliggørelsen af regnskabet for tredje kvartal 2017
November 01, 2017 12:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, 1. november 2017 - Bavarian...
Bavarian Nordic to Host Third Quarter 2017 Results Conference Call
November 01, 2017 12:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark - November 1, 2017 -...
Bavarian Nordic indgår kontrakt med den amerikanske regering om levering af frysetørret IMVAMUNE koppevaccine
September 27, 2017 16:17 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Den indledende kontrakt er på USD 100 mio.,...
Bavarian Nordic Secures Contract Award for Supply of Freeze-dried IMVAMUNE Smallpox Vaccine to the U.S. Government
September 27, 2017 16:17 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Initial base award secures additional...
Bavarian Nordic opdaterer på sin universelle vaccine mod RS-virus (RSV)
September 21, 2017 04:13 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Foreløbige opfølgningsresultater fra fase 2...
Bavarian Nordic Provides Update on its Universal RSV Vaccine
September 21, 2017 04:13 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Preliminary 6 Month Phase 2 Data...
Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic's Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer
September 14, 2017 16:01 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Conference call scheduled for 2:00 PM...
Den uafhængige dataovervågningskomité anbefaler at stoppe Bavarian Nordics fase 3 forsøg med PROSTVAC i patienter med prostatakræft
September 14, 2017 16:01 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Telefonkonference vil blive afholdt...
Bavarian Nordic afholder kapitalmarkedsdag i New York
September 14, 2017 08:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 14. september 2017 -...